Dysport - 300 unit/vial Item# 5005281

Old Dominion University in Virginia awarded contract PO05438588 to McKesson Corporation on August 13, 2026. The contract carries a cumulative value of $3,078.90 and covers the supply of pharmaceutical products. The primary line item consists of Dysport (botulinum toxin type A), a therapeutic injectable agent, with an order quantity of five vials containing 300 units each at a unit price of $615.78 per vial.

The contract represents a direct procurement of pharmaceutical supplies by the educational institution through the prime contractor McKesson Corporation, a major pharmaceutical distribution and healthcare services provider. No specific period of performance or place of performance beyond the awarding organization has been detailed in the contract documentation. The modest contract value and single-line-item nature suggest this represents a discrete purchase order rather than an ongoing supply agreement.